Pharmacoinvasive strategy in the treatment of acute myocardial infarction: current state-of-the-art
Open Access
- 7 July 2021
- journal article
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 26 (2S), 4452
- https://doi.org/10.15829/1560-4071-2021-4452
Abstract
The existing clinical guidelines identify two main approaches to the treatment of patients with ST-segment elevation myocardial infarction: a primary percutaneous coronary intervention and a pharmacoinvasive strategy. Due to the time delays due to various reasons, it is not always easy to perform primary percutaneous coronary intervention timely (<120 minutes). Modern thrombolytic drugs make it easy and safe to apply a pharmacoinvasive strategy to a wide group of patients, improving their prognosis.Keywords
This publication has 19 references indexed in Scilit:
- 2020 Clinical practice guidelines for Acute ST-segment elevation myocardial infarctionRussian Journal of Cardiology, 2020
- 2020 Clinical practice guidelines for Chronic heart failureRussian Journal of Cardiology, 2020
- SWEDEHEART-1-year data show no benefit of newer generation drug-eluting stents over bare-metal stents in patients with severe kidney dysfunction following percutaneous coronary interventionCoronary Artery Disease, 2020
- Correction to: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice GuidelinesJournal of the American College of Cardiology, 2019
- 2019 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Guidelines on the Acute Management of ST-Elevation Myocardial Infarction: Focused Update on Regionalization and ReperfusionCanadian Journal of Cardiology, 2019
- Meta-Analysis Comparing Primary Percutaneous Coronary Intervention Versus Pharmacoinvasive Therapy in Transfer Patients with ST-Elevation Myocardial InfarctionThe American Journal of Cardiology, 2018
- 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevationEuropean Heart Journal, 2015
- Time to treatment as a quality metric for acute STEMI careThe Lancet, 2015
- Corrigendum to: Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countriesEuropean Heart Journal, 2014
- System Delay and Mortality Among Patients With STEMI Treated With Primary Percutaneous Coronary InterventionJAMA, 2010